monoclonal gammopathy of unknown significance (mgus) & importance of regularly monitoring patients
Published 7 years ago • 3.5K plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
2:02
how to manage monoclonal gammopathy of undetermined significance (mgus)
-
0:56
prevalence of mgcs among patients with monoclonal gammopathies
-
2:19
hematology in focus: mgus with clinical significance
-
5:11
istopmm: the psychological effects of mgus screening and changes to clinical presentation of myeloma
-
8:01
mgus: getting rid of pain naturally
-
5:34
mgus understanding diagnosis
-
5:02
monoclonal gammopathy of undetermined significance study
-
1:47
risk stratification of mgus
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:25
the importance of early treatment in mgrs & the role of the mdt
-
2:16
what does the future of mgus look like?
-
1:30
daratumumab for patients with monoclonal gammopathy of renal significance
-
2:42
the importance of better identifying individuals with mgus & the possibility of treating precursors
-
2:47
istopmm analysis results: autoimmune diseases are not associated with mgus
-
9:25
mgus diagnosis: a step-by-step approach
-
5:30
changing perceptions of mgus progression: explaining the data
-
2:19
mgus: predicting the risk of progression
-
1:38
the genomic definition of high-risk myeloma
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
2:01
redefining mgus to better predict progression to active disease
-
1:50
long non-coding rna expression in igm-mgus and waldenström’s macroglobulinemia